Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m‐hydroxymexiletine

Publisher： John Wiley & Sons Inc

E-ISSN： 2052-1707|3|5|n/a-n/a

ISSN： 2052-1707

Source： Pharmacology Research & Perspectives, Vol.3, Iss.5, 2015-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Improved Synthesis of m-Hydroxymexiletine, a Potent Mexiletine Metabolite

By  

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-06 ,pp. : 124-128

Bentham Science Publishers

Access to resources Recommend Favorite

The Interactions Between hERG Potassium Channel and Blockers

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 330-338

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced Repolarization Capacity: New Potential Antiarrhythmic Strategy Based on hERG Channel Activation

By  

Current Medicinal Chemistry, Vol. 18, Iss. 24, 2011-08 ,pp. : 3607-3621

Bentham Science Publishers

Access to resources Recommend Favorite

Stereospecific Synthesis of m-Hydroxymexiletine Enantiomers

By  

Drug Metabolism Letters, Vol. 6, Iss. 3, 2012-01 ,pp. : 182-186

Bentham Science Publishers

Access to resources Recommend Favorite

The hERG channel as target and anti-target

By Lamers Christina   Schubert-Zsilavecz Manfred  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 337-343

Govi-Verlag

Access to resources Recommend Favorite